Development of Pharmacokinetic and Safety Assessment of in vivo Virus Infection and Vaccine Therapy
Development of Pharmacokinetic and Safety Assessment of in vivo Virus Infection and Vaccine Therapy
批准号:
07557174
负责人:
TERASAKI Tetsuya
金额:
$6.14万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
阐明病毒感染的器官嗜性机制在基因和疫苗治疗中具有重要意义。本研究选择已知的脊髓灰质炎病原体脊髓灰质炎病毒作为模型病毒,用于疫苗治疗的安全性评价和基于药代动力学分析的体内病毒感染预测。携带人类脊髓灰质炎病毒受体(PVR)基因的转基因(TG)小鼠对静脉接种脊髓灰质炎病毒(IV)易感,已用于体内感染研究。为了了解PVR对静脉接种脊髓灰质炎病毒的组织分布和血脑屏障通透性的影响,我们在Tg小鼠和非Tg小鼠之间对这些过程进行了研究和比较。脊髓灰质炎病毒在转基因小鼠体内的分布与非转基因小鼠相似,提示脊髓灰质炎病毒在组织中的分布不依赖于转基因的PVR。脊髓灰质炎病毒转移到中枢神经系统后,无论是强毒株还是弱毒株,病毒似乎都以大约0.2ul/min/g脑的恒定速度累积。当病毒接种到非转基因小鼠身上时,也观察到了类似的现象。这些数据表明,脊髓灰质炎病毒以相当高的速度渗透到血脑屏障中,与PVR和VERUS株无关。如果在人类中也是如此,包括沙宾疫苗株在内的循环中的脊髓灰质炎病毒很容易入侵人的中枢神经系统。除PVR之外的一些分子可能参与了脊髓灰质炎病毒的血脑屏障通透性。
英文摘要
It is significantly important subjict to elucidate the mechanism of organ tropism of virus infection in gene and vaccine therapy. In the present study, poliovirus, known to be the causative agent of poliomyelitis, has been selected as a model virus to develop the safety assesement of vaccine therapy and to predict the in vivo virus infection in the body based on pharmacokinetic analysis. The transgenic (Tg) mice carrying the human gene for poliovirus receptor (PVR), which is susceptible to intraven ously (IV) -inoculated poliovirus, has been used for the in vivo enfection studies. To know cotribution of PVR to tissue distribution and BBB permeability of IV-inoculated polioviruses, these processes were investigated and compared between the Tg mice and non-Tg mice. Distribution profile of IV-inoculated poliovirus in various tissues of the Tg mice is similar to that in non-Tg mice, suggesting that tissue distribution of IV-inoculated virus is independent of the transgene for PVR.Amount of poliovirus transfered to the CNS demonstrates an existence of specific invasion pathway for the virus to the CNS.The viruses, regardless of whether the virulent and attenuated strain, seem to accumulate at a constant rate of approximately 0.2ul/min/g brain. Similar phenomena were observed when the viruses were inoculated into non-Tg mice. These data suggest that polioviruses permeate the BBB at a fairly high rate, independently of PVR and verus strains. If it is also true in humans, circulating poliovirus including the Sabin vaccine strains easily invade the human CNS.Some molecules other than PVR may be involved in the BBB permeability of poliovirus.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
水野 尚美: "DDSの進歩IV(Progress in Drug Delivery System)" 岡田 昌二 編、バイオメディカル社、東京, 161 (1995)
Naomi Mizuno:“Progress in Drug Delivery System IV”,由 Shoji Okada 编辑,Biomedical Publishing,东京,161 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
掛江敦之: "血液脳関門-静的障壁からダイナミックインターフェースへ-脳へのドラッグデリバリーの最近の進歩 その5" Pharm Tech Japan.12. 19-32 (1996)
Atsuyuki Kakee:“血脑屏障 - 从静态屏障到动态界面 - 大脑药物输送的最新进展第 5 部分”Pharm Tech Japan.19-32 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takeo Kitazawa: "Blood-brain barrier-Static wall to dynamic interface-Recent advance in drug delivery to the brain,Part 7" Pharm Tech Japan. 12. 315-329 (1996)
Takeo Kitazawa:“血脑屏障-静态壁到动态界面-大脑药物输送的最新进展,第 7 部分”Pharm Tech Japan。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Atsuyuki Kakee: "Blood-brain barrier-Static wall to dynamic interface-Recent advance in drug delivery to the brain,Part 4" Pharm Tech Japan. 11. 1321-1333 (1995)
Atsuyuki Kakee:“血脑屏障 - 静态壁到动态界面 - 大脑药物输送的最新进展,第 4 部分” Pharm Tech Japan。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
寺崎 哲也: "DDSの進歩 1995-96(Molecular Medicine 別冊)" 水島 裕 編、中山書店、東京, 267 (1995)
Tetsuya Terasaki:“Advances in DDS 1995-96(分子医学特刊)”由 Yutaka Mizushima 编辑,Nakayama Shoten,Tokyo,267(1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
PROTEOMICS-BASED ANALYSIS OF BLOOD-BRAIN BARRIER TRANSPORT SYSTEM
-
批准号:18109002
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$71.14万
-
财政年份:2006
-
负责人:TERASAKI Tetsuya
-
依托单位:
Physiological role of the blood-brain barrier transportsome
-
批准号:17081002
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$37.25万
-
财政年份:2005
-
负责人:TERASAKI Tetsuya
-
依托单位:
Physiological study on the transport functions at the blood-brain barrier relating to neural disorders.
-
批准号:14207104
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$28.54万
-
财政年份:2002
-
负责人:TERASAKI Tetsuya
-
依托单位:
Development of new drug screening system using the blood-brain barrier transporter gene expression
-
批准号:12557215
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2000
-
负责人:TERASAKI Tetsuya
-
依托单位:
cDNA cloning of blood-brain barrier neurotransmitter transporter and analysis of its physiological function
-
批准号:12470522
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2000
-
负责人:TERASAKI Tetsuya
-
依托单位:
Development of in vitro blood-brain barrier culture system from temperature sensitive SV40T antigen gene transgenic animal
-
批准号:10557227
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:1998
-
负责人:TERASAKI Tetsuya
-
依托单位:
Functional multiplicity of blood-brain barrier transporters as a detoxifying system of the brain
-
批准号:10470507
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:1998
-
负责人:TERASAKI Tetsuya
-
依托单位:
Molecular design of drug efflux system modulator at blood-brain barrier
-
批准号:08457619
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.8万
-
财政年份:1996
-
负责人:TERASAKI Tetsuya
-
依托单位:
Drug Delivery to the Brain Using Cell Adhesion Molecule
-
批准号:06452376
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1994
-
负责人:TERASAKI Tetsuya
-
依托单位:
海外基金